Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma

Predictive biomarkers of the response of hepatocellular carcinoma (HCC) to Lenvatinib therapy have not yet been clarified. The aim of this study was to identify clinically significant biomarkers of response to Lenvatinib therapy, to target strategies against HCC. Levels of circulating angiogenic fac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Chuma, Makoto, Uojima, Haruki, Numata, Kazushi, Hidaka, Hisashi, Toyoda, Hidenori, Hiraoka, Atsushi, Tada, Toshifumi, Hirose, Shunji, Atsukawa, Masanori, Itokawa, Norio, Arai, Taeang, Kako, Makoto, Nakazawa, Takahide, Wada, Naohisa, Iwasaki, Shuitirou, Miura, Yuki, Hishiki, Satoshi, Nishigori, Shuhei, Morimoto, Manabu, Hattori, Nobuhiro, Ogushi, Katsuaki, Nozaki, Akito, Fukuda, Hiroyuki, Kagawa, Tatehiro, Michitaka, Kojiro, Kumada, Takashi, Maeda, Shin
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7073176/
https://ncbi.nlm.nih.gov/pubmed/31991869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12020293
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados